2018 Drug Design and Delivery Symposium
We are planning a diverse set of broadcasts for this year’s symposium and will highlight new fields of research exploring new ways to look issues that medicinal chemists are facing. The details for upcoming broadcasts will be posted as they are finalized.
| Jan 25 | A New Strategy in Drug Discovery: Protac-Induced Protein Degradation Ian Churcher - BenevolentBio Aaron Balog - Bristol-Myers Squibb |
| Feb 22 | Women in Drug Discovery and Development: How to Succeed as a Female in Academia and Industry Annette Bak - AstraZeneca Donna Huryn - University of Pittsburgh Erika Araujo - Bristol-Myers Squibb Nurulain Zaveri - Astraea Therapeutics |
| Mar 29 | A Nanomedicine Overview for mRNA Delivery: Innovative Methods Using Lipid Nanoparticles Marianna Yanez Arteta - AstraZeneca Dennis Lueng - Genentech |
| Apr 26 | Nanomaterials for Fighting Antibiotic-Resistant Bacteria Vincent Rotello - University of Massachusetts at Amherst Christopher England - American Chemical Society |
| May 31 | Advanced Nano-Delivery Systems: Facilitating Tumor Delivery and Mitigating Resistance Mansoor Amiji - Northeastern University Venkat Krishnamurthy - AstraZeneca |
| Jun 28 | Pitfalls and Promise of Central Nervous System Drug Discovery Valentin Gribkoff - Yale University Nicholas Meanwell - Bristol-Myers Squibb |
| Jul 26 | How to Optimize Central Nervous System Therapeutics: Med Chem Strategies, Tactics, and Workflows Craig Lindsley - Vanderbilt Center for Neuroscience Drug Discovery Amy Newman - Intramural Research Program, NIH |
| Sept 20 | A Novel Strategy for the Treatment of Chronic Pain: Antagonising PAR2 with a Monoclonal Antibody Pete Thornton - AstraZeneca Nurulain Zaveri - Astraea Therapeutics |
| Oct 18 | Central Nervous System Medicinal Chemistry |
| Nov 29 | Special Topic |
;void(0);){kind=link}